↓ Skip to main content

The effect of bee propolis on recurrent aphthous stomatitis: a pilot study

Overview of attention for article published in Clinical Oral Investigations, February 2007
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter
5 X users
patent
1 patent
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
84 Dimensions

Readers on

mendeley
128 Mendeley
connotea
1 Connotea
Title
The effect of bee propolis on recurrent aphthous stomatitis: a pilot study
Published in
Clinical Oral Investigations, February 2007
DOI 10.1007/s00784-006-0090-z
Pubmed ID
Authors

Nachum Samet, Caroline Laurent, Srinivas M. Susarla, Naama Samet-Rubinsteen

Abstract

Recurrent aphthous stomatitis (RAS) is a common, painful, and ulcerative disorder of the oral cavity of unknown etiology. No cure exists and medications aim to reduce pain associated with ulcers through topical applications or reduce outbreak frequency with systemic medications, many having serious side effects. The purpose of this pilot study was to evaluate the potential of a product to reduce the number of outbreaks of RAS ulcers. Propolis is a bee product used in some cultures as treatment for mouth ulcers. In this randomized, double-blind, placebo-controlled study, patients were assigned to take 500 mg of propolis or a placebo capsule daily. Subjects reported a baseline ulcer frequency and were contacted biweekly to record recurrences. Data were analyzed to determine if subjects had a decrease of 50% in outbreak frequency. The data indicated a statistically significant reduction of outbreaks in the propolis group (Fisher's exact test, one sided, p = 0.04). Patients in the propolis group also self-reported a significant improvement in their quality of life (p = 0.03). This study has shown propolis to be effective in decreasing the number of recurrences and improve the quality of life in patients who suffer from RAS. Propolis should be evaluated further in a larger sample clinical trial.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 128 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Egypt 1 <1%
Unknown 126 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 21 16%
Researcher 17 13%
Student > Bachelor 17 13%
Student > Ph. D. Student 12 9%
Other 8 6%
Other 28 22%
Unknown 25 20%
Readers by discipline Count As %
Medicine and Dentistry 46 36%
Chemistry 12 9%
Agricultural and Biological Sciences 11 9%
Nursing and Health Professions 10 8%
Pharmacology, Toxicology and Pharmaceutical Science 6 5%
Other 13 10%
Unknown 30 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 October 2021.
All research outputs
#3,147,076
of 23,070,218 outputs
Outputs from Clinical Oral Investigations
#85
of 1,434 outputs
Outputs of similar age
#12,986
of 161,537 outputs
Outputs of similar age from Clinical Oral Investigations
#2
of 5 outputs
Altmetric has tracked 23,070,218 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,434 research outputs from this source. They receive a mean Attention Score of 3.7. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 161,537 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.